NCT05523609 2023-12-01
Vitamin D and Calcium Supplementation in Breast Cancer
Tanta University
Phase 2/3 Unknown
Clinical Trials
6 trialsNCT03507465 2018-04-25
Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer
Guangdong Provincial People's Hospital
Phase 2/3 Unknown
NCT03373708 2017-12-18
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2/3 Unknown
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT00535418 2017-09-05
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
Novartis
Phase 2/3 Completed
NCT00333047 2009-11-19
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
Novartis
Phase 2/3 Completed